Centers | ||
|
|
|
Centre for Collaborative Drug Research | UCSC Chemical Screening Center | Therapeutic Accelerator Program (TAP) |
The Centre for Collaborative Drug Research is a multidisciplinary initiative bringing together the Faculties of Medicine and Pharmacy at the University of Toronto, Canadas leading academic institution and largest research entity, and the Centre... |
We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... |
Test |
Partnerships |
Events |
Jobs |
Senex BiotechnologyThe mission of Senex Biotechnology is to discover and develop therapeutic agents to effectively treat cancer, viral diseases and age-related diseases, such as Alzheimer's, renal disease, atherosclerosis, and arthritis, by targeting damage-inducible... View all Janssen Partners with Evotec-Harvard Diabetes Collaboration ProgramJanssen Pharmaceutical a division of Johnson & Johnson has entered into partnership with Harvard University - Evotec's Diabetes program called CureBeta. Janssen will paying $300million in milestone payments per product in addition to $8million in... View all Evotec and Yale University to collaborate on cancer therapyEvotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this collaboration is to identify novel mechanisms, targets and... View all |
No EVENTS for listing |
No Job Posts |
